Symptoms
Diethylstilbestrol: a public health disaster
A multi-use artificial hormone, Diethylstilbestrol was controversial from its discovery, with the inventor of the drug warning of possible side effects. Its impact on...
A new approach to managing OA of the knee
New guidelines sideline surgery, injectable medicines and opioids for primary healthcare management of knee osteoarthritis.
How pharmacists can address the risk of gabapentinoids
New boxed warnings for pregabalin and gabapentin give pharmacists the opportunity to discuss pain management with patients.
Don’t let a cold chain breach take you by surprise
From manual temperature checks to proper vaccine packaging, here’s what pharmacists need to know to protect patients, stock – and reputations.
COVID-19: How should pharmacists play a role?
Coronavirus (COVID-19) information for pharmacistsFor PSA’s latest information, updates and advice on the novel coronavirus outbreak, click here.
Pharmacists, the most accessible healthcare professionals, are...
How to talk patients’ language
Australia prides itself on its multicultural chemistry, but it presents everyday challenges. Community pharmacy services can play their part by catering specifically for people...
